Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare to Provide Diagnostic Tools to Indian Research Hospital

NEW YORK, May 26 (GenomeWeb News) - GE Healthcare will provide certain of its diagnostic tools to a large hospital and research center on the outskirts of New Delhi, India, according to a report in the India-based Business Standard.

 

GE "is not investing in cash" in the hospital, called Medicity, Jeffery Immelt, chairman and CEO of GE Worldwide, said in a statement to reporters attending the signing of the agreement, according to the online newswire. "We will provide the world-class technology for high-end diagnostic tools, clinical research and development and eco-friendly solutions."

 

Immelt said GE does not rule out equity partnership in Medicity, the Standard said.

 

GenomeWeb News could not immediately confirm the account.

 

In addition to research tools, the "memorandum of understanding" GE signed with Medicity project head Naresh Trehan said GE will provide the project with utility services, such as power generation and distribution and lighting and water treatment, the report said.

 

Trehan is the chief cardiothoracic and vascular surgeon at Escorts Heart Institute and ResearchCenter in New Delhi.

 

Medicity, based in Guragon, is planned to be a 43-acre, 1,800-bed hospital and research center that will cost approximately $250 million. The project is slated for completion in 2007.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.